CN120053481A - 原子量子簇的治疗用途 - Google Patents

原子量子簇的治疗用途 Download PDF

Info

Publication number
CN120053481A
CN120053481A CN202510224683.7A CN202510224683A CN120053481A CN 120053481 A CN120053481 A CN 120053481A CN 202510224683 A CN202510224683 A CN 202510224683A CN 120053481 A CN120053481 A CN 120053481A
Authority
CN
China
Prior art keywords
composition
aqcs
cancer
cells
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202510224683.7A
Other languages
English (en)
Chinese (zh)
Inventor
D·布塞塔费尔南德斯
F·多明格斯普恩特
M·A·罗培斯昆特拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Santiago de Compostela
Nanogap Sub NM Powder SA
Original Assignee
University of Santiago de Compostela
Nanogap Sub NM Powder SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Santiago de Compostela, Nanogap Sub NM Powder SA filed Critical University of Santiago de Compostela
Publication of CN120053481A publication Critical patent/CN120053481A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/05—Metallic powder characterised by the size or surface area of the particles
    • B22F1/054—Nanosized particles
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C5/00—Alloys based on noble metals
    • C22C5/06—Alloys based on silver
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25C—PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS; APPARATUS THEREFOR
    • C25C1/00—Electrolytic production, recovery or refining of metals by electrolysis of solutions
    • C25C1/12—Electrolytic production, recovery or refining of metals by electrolysis of solutions of copper
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25C—PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS; APPARATUS THEREFOR
    • C25C1/00—Electrolytic production, recovery or refining of metals by electrolysis of solutions
    • C25C1/20—Electrolytic production, recovery or refining of metals by electrolysis of solutions of noble metals
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25C—PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS; APPARATUS THEREFOR
    • C25C5/00—Electrolytic production, recovery or refining of metal powders or porous metal masses
    • C25C5/02—Electrolytic production, recovery or refining of metal powders or porous metal masses from solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F2202/00—Treatment under specific physical conditions
    • B22F2202/11—Use of irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Nanotechnology (AREA)
  • Electrochemistry (AREA)
  • Mechanical Engineering (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202510224683.7A 2018-09-26 2019-09-25 原子量子簇的治疗用途 Pending CN120053481A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP18196959.3 2018-09-26
EP18196963.5 2018-09-26
EP18196963 2018-09-26
EP18196959 2018-09-26
CN201980063142.3A CN113179632A (zh) 2018-09-26 2019-09-25 原子量子簇的治疗用途
PCT/ES2019/070637 WO2020065115A2 (es) 2018-09-26 2019-09-25 Usos terapéuticos de clústeres cuánticos atómicos

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201980063142.3A Division CN113179632A (zh) 2018-09-26 2019-09-25 原子量子簇的治疗用途

Publications (1)

Publication Number Publication Date
CN120053481A true CN120053481A (zh) 2025-05-30

Family

ID=68342935

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202510224683.7A Pending CN120053481A (zh) 2018-09-26 2019-09-25 原子量子簇的治疗用途
CN201980063142.3A Pending CN113179632A (zh) 2018-09-26 2019-09-25 原子量子簇的治疗用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201980063142.3A Pending CN113179632A (zh) 2018-09-26 2019-09-25 原子量子簇的治疗用途

Country Status (11)

Country Link
US (1) US20220031740A1 (enExample)
EP (1) EP3862109A2 (enExample)
JP (2) JP2022502450A (enExample)
KR (1) KR20210086606A (enExample)
CN (2) CN120053481A (enExample)
AU (2) AU2019349780B2 (enExample)
BR (1) BR112021005775A2 (enExample)
CA (1) CA3111915A1 (enExample)
IL (1) IL281663A (enExample)
MX (1) MX2021003566A (enExample)
WO (1) WO2020065115A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1303421C (zh) * 2004-03-24 2007-03-07 南京大学 一种用于有机氯、有机磷农药分析的同步净化提取方法
JP7595087B2 (ja) * 2020-05-09 2024-12-05 深▲セン▼深見医薬科技有限公司 非定型抗精神病薬による副作用の治療
CN111906328B (zh) * 2020-08-11 2022-10-25 苏州大学 一种177Lu标记的金纳米团簇及其制备方法和应用
JP2025034223A (ja) * 2023-08-30 2025-03-13 株式会社ハイレックスコーポレーション ワイヤロープ
WO2026124952A1 (fr) * 2024-12-13 2026-06-18 Saint-Gobain Glass France Substrat verrier antimicrobien

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2277531B2 (es) * 2005-08-03 2008-07-16 Universidad De Santiago De Compostela Procedimiento para la obtencion de clusteres cuanticos atomicos.
CN101113046A (zh) * 2006-07-25 2008-01-30 安正五 纳米胶体银水的制备方法
ES2319064B1 (es) * 2007-10-05 2010-02-15 Universidad De Santiago De Compostela Uso de clusteres cuanticos atomicos (aqcs) como antimicrobianos y biocidas.
CN101486733B (zh) * 2009-03-09 2011-05-25 华南师范大学 含氧桥双核钼原子簇化合物及其制备方法和用途
EP2457572A1 (en) * 2010-11-05 2012-05-30 Universidade De Santiago De Compostela Use of atomic quantum clusters (aqcs) in the prevention of cell proliferative disorders, viral infections and autoimmune diseases
WO2015015301A2 (en) * 2013-07-31 2015-02-05 Palama Ilaria El Cancer therapy with silver nanoparticles
KR102975187B1 (ko) * 2018-06-12 2026-06-08 나노갭 서브-엔엠-파우더, 쏘시에다드 아노니마 정제된 원자 양자 클러스터를 제조하는 방법

Also Published As

Publication number Publication date
BR112021005775A2 (pt) 2021-06-29
KR20210086606A (ko) 2021-07-08
WO2020065115A3 (es) 2020-05-22
CA3111915A1 (en) 2020-04-02
JP2022502450A (ja) 2022-01-11
EP3862109A2 (en) 2021-08-11
AU2025238114A1 (en) 2025-10-23
JP2024122998A (ja) 2024-09-10
AU2019349780A1 (en) 2021-03-25
WO2020065115A2 (es) 2020-04-02
US20220031740A1 (en) 2022-02-03
MX2021003566A (es) 2021-08-16
IL281663A (en) 2021-05-31
CN113179632A (zh) 2021-07-27
AU2019349780B2 (en) 2025-07-03

Similar Documents

Publication Publication Date Title
AU2019349780B2 (en) Therapeutic uses of atomic quantum clusters
Narayana et al. Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges
Mao et al. Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond
Pan et al. Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection
CN103608139B (zh) 表面改性的重金属纳米粒子、组合物及其用途
Akter et al. Gold nanoparticles in triple-negative breast cancer therapeutics
US9163063B2 (en) Peptides and nanoparticles for therapeutic and diagnostic applications
US10688125B2 (en) Nanoparticles and their use in cancer therapy
Tung et al. One-stop radiotherapeutic targeting of primary and distant osteosarcoma to inhibit cancer progression and metastasis using 2DG-grafted graphene quantum dots
WO2017048944A1 (en) High-z nanoparticles and the use thereof in radiation therapy
WO2020031136A1 (en) Theranostics-like protein sanps conjugated to integrin and pmsa targeting peptides and therapy of prostate cancer
Hu et al. Biomineralized Cu-disulfiram nanoparticles potentiate colorectal cancer immunotherapy through synergistic cuproptosis and apoptosis
US20070117784A1 (en) Treatment of hyperproliferative diseases with anthraquinones
US10035806B2 (en) Derivatized corroles and metallocorroles and their use as imaging and therapeutic agents
US20130252904A1 (en) Compositions and methods for treating cancer
Eiblmaier et al. The role of p53 in the trafficking of copper-64 to tumor cell nuclei
HK40057518A (en) Therapeutic uses of atomic quantum clusters
Wang et al. Repurposing antihistamine to chemotherapy via a molecular delivery platform co-targeting mitochondria and endoplasmic reticulum
US20230381349A1 (en) Methods and compositions for imaging and treating cancer
US20260084978A1 (en) Process for producing atomic quantum clusters derivatives
WO2021107794A1 (en) Method of making a system containing gold nanoparticles and use of the system in antitumor therapy
CN101193644A (zh) 使用蒽醌类治疗过度增殖性疾病
Wang et al. Versatile Nanotherapeutics for Enhancing Sonodynamic Therapy/Chemotherapy of Thyroid Cancer through Remodeling Tumor Microenvironment and Synergistic Reactive Oxygen Species Augment
Fong The potential use of cucurbiturils and cyclodextrins to facilitate delivery and anti-neoplastic potentiation of tirapazamine and cisplatin with concurrent radiotherapy in tumours–A quantum mechanical study
WO2026036187A1 (en) Methods of treating cns cancers

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination